Related Experiment Video
Updated: Jul 1, 2026
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Medicine reimbursement recommendations in Canada, Australia, and Scotland
Joel Lexchin1, Barbara Mintzes
1School of Health Policy and Management, York University, 4700 Keele St, Toronto, Ontario, Canada M3J 1P3. jlexchin@yorku.ca
Objective:
This study was undertaken to compare the recommendations made by the Canadian Common Drug Review (CDR) regarding whether drugs should be listed on provincial and federal formularies with recommendations made by similar bodies in other countries.
Study Design:
Retrospective cohort analysis.
Methods:
All recommendations made by CDR until September 30, 2006, were accessed. Two comparable agencies, the Australian Pharmaceutical Benefits Advisory Committee (PBAC) and the Scottish Medicines Consortium (SMC), were identified, and recommendations were obtained from the Web sites of all 3 agencies. We examined whether each of the agencies put equal proportions of drugs into each of 3 categories: unrestricted listing, listing with criteria, and do not list. Second, we compared recommendations on individual drugs.
Results:
CDR made recommendations on 47 drugs. PBAC and SMC made recommendations about 31 and 29 of these products, respectively. There was no statistically significant difference in the percentage of drugs assigned to each category of recommendation in comparisons between CDR and PBAC, and between CDR and SMC. There was moderate agreement between CDR and PBAC for recommendations on individual drugs and poor agreement between CDR and SMC.
Conclusions:
CDR is no different from other similar agencies in terms of the number of drugs recommended for full or restricted listing, or against listing. There is a relatively low level of agreement on recommendations about individual drugs among the different agencies. These differences appear to be because of pharmacoeconomic evaluations and likely reflect discrepancies between countries in national markets and health systems.
Related Concept Videos
01:30Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:29Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:26Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:02Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:15Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...